Safety and efficacy outcomes for patients ages 65 and older treated with dose-dense chemotherapy for epithelial ovarian cancer von Teplinsky, Eleonora, Caldwell, Haven Lindsay, Kohn, Nina, Cheng, Kit, Hoffman, Mark Allan, Dos Santos, Lisa A., Sakaris, Antoinette, Shih, Karin, Lovecchio, John L., Whyte, Jill Suzanne, Menzin, Andrew, John, Veena S.

Volltext

Association of MiR-26b mediated doxorubicin resistance signature with poor prognosis in epithelial ovarian cancer (EOC) von Korsunsky, Ilya, Parameswaran, Janaki, Shapira, Iuliana, Oswald, Michaela, Lovecchio, John L., Menzin, Andrew, Whyte, Jill Suzanne, Dos Santos, Lisa A., Liang, Sharon, Bhuiya, Tawfiqul Alam, Keogh, Mary, Mason, Cathleen, Khalili, Houman, Fastuca, Meagan, Pond, Cassandra, Liew, Anthony, Gregersen, Peter, Lee, Annette

Volltext

Correlation of in vitro chemotherapy drug resistance assay to clinical response to carboplatin and paclitaxel combination chemotherapy in ovarian carcinoma von Cheng, Kit, Shapira, Iuliana, Rosen, Lisa M, John, Veena S., Lovecchio, John L., Menzin, Andrew, Whyte, Jill Suzanne, Dos Santos, Lisa A., Contreras, Diana, Shih, Karin, Roy, Rajasree, Lee, Annette, Hayes, Christi, Ahmad, Nazish, Tandon, Pragati, Hoffman, Mark Allan

Volltext

Cumulative effect of evidence-based practices on outcomes of preterm infants born at <29 weeks’ gestational age von Rizzolo, Angelo, Shah, Prakesh S., Boucorian, Isabelle, Lemyre, Brigitte, Bertelle, Valerie, Pelausa, Ermelinda, St Hilaire, Marie, Dahlgren, Leanne, Beltempo, Marc

Volltext